SCPX(Delisted)
Scorpius HoldingsยทAMEX
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SCPX
Scorpius Holdings, Inc.
A professional biological formulation Contract Development and Manufacturing Organization (CDMO)
627 Davis Drive, Suite 400, Morrisville, North Carolina 27560
--
Scorpius Holdings, Inc., was incorporated on June 10, 2008 under the laws of the State of Delaware. Scorpius Holdings, through its subsidiary, Scorpius BioManufacturing, an integrated contract development and manufacturing organization (CDMO), focuses on rapidly advancing biological and cell therapy programs into clinical and other fields. Scorpius provides a wide range of analytical testing, process development and manufacturing services to pharmaceutical and biotechnology companies at its state-of-the-art facility in San Antonio, Texas.
Company Financials
EPS
SCPX has released its 2024 Q3 earnings. EPS was reported at -1.43, versus the expected 0, missing expectations. The chart below visualizes how SCPX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SCPX has released its 2024 Q3 earnings report, with revenue of 922.37K, reflecting a YoY change of 27.55%, and net profit of -10.55M, showing a YoY change of 26.32%. The Sankey diagram below clearly presents SCPX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
